Revelation Biosciences, Inc. · NASDAQ:REVB

Zygmont Chester Stanley III received 208,073 Revelation Biosciences, Inc. shares as an award (Form 4)

Traded Aug 17, 2026 · Filed Aug 18, 2026

On Aug 17, 2026, Zygmont Chester Stanley III (Chief Financial Officer) received 208,073 Revelation Biosciences, Inc. shares as an award, leaving 0 shares. Filed Aug 18, 2026 (Form 4).

Awarded
208,073 shares
Holding after
0 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 17, 2026Common StockAward208,073208,073Direct
Aug 17, 2026Common StockGift208,0730Direct

Source

View original at SEC

Related